Dr. @[Herman Weiss](user:94004), I appreciate your reply and hope the roadshow went well. Please forgive a squeaky wheel looking for grease. A few follow-ups:
1. Did Todos/Amarantus/Breakthrough apply for the ADDF/Gates Diagnostic Accelerator? 1b. Did that application include any PET comparison data? 1c. If not, why?
2. Are you saying KOLs and potential clinical partners have not given you any firm metrics to meet? 2b. From your second response am I to take it the firm would be pleased with approx 90%s/s? Given the prior history of this diagnostic, the market would appreciate clarity and disciplined talk when it comes to efficacy.
3. Did you have the Lympro PET1 data in hand before you finalized the acquisition/partnership?
A real shame @[Herman Weiss](user:94004) or @[Terry Chrisomalis](user:5023) won't answer this. You've had almost a week fellas. Seems to say it all....
Terry/Herman, how did you evaluate the Lympro2.0 PET 1 data? I haven't seen that publicly released. And where did you see it could be as high as 90%? That would be great if it was, is that sens/spec or what? What are have KOLs or potential industry partners set as diagnostic goalposts?
Latest Comments
Finally A Real Cancer Diagnosis Breakthrough?
Dr. @[Herman Weiss](user:94004), I appreciate your reply and hope the roadshow went well. Please forgive a squeaky wheel looking for grease. A few follow-ups:
1. Did Todos/Amarantus/Breakthrough apply for the ADDF/Gates Diagnostic Accelerator? 1b. Did that application include any PET comparison data? 1c. If not, why?
2. Are you saying KOLs and potential clinical partners have not given you any firm metrics to meet? 2b. From your second response am I to take it the firm would be pleased with approx 90%s/s? Given the prior history of this diagnostic, the market would appreciate clarity and disciplined talk when it comes to efficacy.
3. Did you have the Lympro PET1 data in hand before you finalized the acquisition/partnership?
Finally A Real Cancer Diagnosis Breakthrough?
A real shame @[Herman Weiss](user:94004) or @[Terry Chrisomalis](user:5023) won't answer this. You've had almost a week fellas. Seems to say it all....
Finally A Real Cancer Diagnosis Breakthrough?
@[Herman Weiss](user:94004) @[Terry Chrisomalis](user:5023)
Finally A Real Cancer Diagnosis Breakthrough?
Terry/Herman, how did you evaluate the Lympro2.0 PET 1 data? I haven't seen that publicly released. And where did you see it could be as high as 90%? That would be great if it was, is that sens/spec or what? What are have KOLs or potential industry partners set as diagnostic goalposts?